e-learning
resources
Vienna 2012
Wednesday, 05.09.2012
COPD exacerbation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical characteristics and determinants of exacerbation in Japanese patients with COPD: Hokkaido COPD cohort study results
M. Suzuki, H. Makita, S. Konno, K. Shimizu, N. Taniguchi, Y. M. Ito, M. Nishimura (Sapporo, Japan)
Source:
Annual Congress 2012 - COPD exacerbation
Session:
COPD exacerbation
Session type:
Poster Discussion
Number:
4809
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Suzuki, H. Makita, S. Konno, K. Shimizu, N. Taniguchi, Y. M. Ito, M. Nishimura (Sapporo, Japan). Clinical characteristics and determinants of exacerbation in Japanese patients with COPD: Hokkaido COPD cohort study results. Eur Respir J 2012; 40: Suppl. 56, 4809
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study
Source: Eur Respir J 2014; 43: 1289-1297
Year: 2014
Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016
Influence of the seasons on exacerbation characteristics in a cohort of COPD patients (EXACO study)
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
Effect of allergic sensitization on clinical course of patients with COPD in the Hokkaido COPD cohort study
Source: International Congress 2014 – COPD physiopathology
Year: 2014
Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021
Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Clinical characteristics and outcomes in hospitalized COVID-19 patients with COPD
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021
Dual bronchodilation in real-life COPD management: analysis of patients’ characteristics enrolled in COPD Registry in Russia
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
Effect of COPD medications on exacerbation rates in a real-life COPD patient cohort - data from the Czech Multicenter Research Database of COPD.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Impact of chronic cough in individuals with COPD: a population-based cohort study
Source: International Congress 2019 – More and more COPD
Year: 2019
Characteristics and outcomes of chronic cough in individuals with asthma: a population-based study
Source: International Congress 2018 – Asthma and allergy in adults and children and their biomarkers
Year: 2018
Persistence of clinical criteria of chronic bronchitis in patients with COPD over time: A longitudinal analysis of the TRACE cohort.
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
General characteristics in our patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 151s
Year: 2004
Interferon-lambda-genotype GG and IgG2 are predictors for frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
Determinants of dyspnea in COPD patients: the French PALOMB cohort
Source: International Congress 2018 – COPD around the world
Year: 2018
Incidence and clinical characteristics of lung cancer in patients with COPD - From Hokkaido COPD cohort study
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016
The characteristics of ACOS in a population based asthma cohort
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept